Viewing Study NCT06607263



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06607263
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-12

Brief Title: Comparative Study of CPCZn Mouthwash Dental Floss and Essential Oils Mouthwash on Plaque and Gingivitis Reduction
Sponsor: None
Organization: None

Study Overview

Official Title: Clinical Study to Evaluate the Efficacy of Rinsing with an Alcohol Free Mouthwash Containing CPCZn As Compared to Dental Flossing and to Rising with an Essential Oils Containing Alcohol Mouthwash in Reducing Dental Plaque and Gingivitis
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PGMWI
Brief Summary: Clinical study evaluating the effectiveness of an alcohol-free mouthwash containing CPCZn compared to dental flossing and an essential oils-containing alcohol mouthwash in reducing dental plaque and gingivitis This is a Phase III single-center double-blind trial with a parallel design It involves 120 participants aged between 18 and 65 randomized into different groups and spans 12 weeks
Detailed Description: This clinical study aims to evaluate the efficacy of an alcohol-free mouthwash containing CPC Cetylpyridinium Chloride and Zinc Zn in reducing dental plaque and gingivitis compared to dental flossing and a mouthwash with essential oils in an alcohol base It is a Phase III randomized double-blind parallel-group trial involving 120 participants aged 18 to 65 Subjects will be divided into three groups-one using the CPCZn mouthwash another using the essential oils mouthwash and a control group using dental floss Each group will also use a fluoride toothpaste and a soft-bristle toothbrush twice daily over 12 weeks The primary efficacy variable is the reduction of gingival inflammation also Probing Depth Bleeding on Probing and a Plaque Index will be accessed Subjects will undergo baseline 4-week and 12-week evaluations with data analyzed using ANCOVA to assess the efficacy and safety of the products Adverse events and compliance will be closely monitored with strict confidentiality maintained for all participants The study rigorous design aims to provide comprehensive insights into the effectiveness of these oral hygiene regimens

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None